Tanalys

NanoCap’s holding MyFirstApp Group enters into an agreement to divest its operations to ObsteCare

Stockholm 2022-11-25

NanoCap’s holding MyFirstApp Group has entered into an agreement to divest its business within Ed-Tech to ObsteCare AB. The purchase price amounts to SEK 22 million, of which SEK 9.7 million is to be paid through newly issued shares in ObsteCare at a rate of SEK 0.05 per share and SEK 12.3 million through reversion. An additional purchase price of a maximum of SEK 10 million must be paid to the seller depending on performance. The additional purchase price is paid 50 percent in the form of shares and 50 percent in cash. The deal is conditional on ObsteCare`s extraordinary general meeting approving the acquisition.

We as owners are positive about the proposed transaction and look forward to MyFirstApp being able to develop together with us and other long-term shareholders.

 

//

This press release is a translation from the main language, which is Swedish.

For more information, contact the company at:

Telephone: +46 (0)8-410 59 140

ir(at)nanocapgroup.com

www.nanocapgroup.com

NanoCap Group AB (publ)

NanoCap invests in growth companies, primarily unlisted, as well as develops and launches its own in-house projects. NanoCap employs a strategy to help each individual target company/investment to prepare for a listing in the near future. NanoCap’s approach is to, beside providing support regarding the listing processes, also to be involved in the respective target companies’ business- and strategy development.

Exit mobile version